Andrei Zlobin

1.9k total citations
18 papers, 1.4k citations indexed

About

Andrei Zlobin is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Andrei Zlobin has authored 18 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Andrei Zlobin's work include Developmental Biology and Gene Regulation (4 papers), Cancer Cells and Metastasis (3 papers) and Epigenetics and DNA Methylation (2 papers). Andrei Zlobin is often cited by papers focused on Developmental Biology and Gene Regulation (4 papers), Cancer Cells and Metastasis (3 papers) and Epigenetics and DNA Methylation (2 papers). Andrei Zlobin collaborates with scholars based in United States, United Kingdom and Poland. Andrei Zlobin's co-authors include Lucio Miele, W. Martin Kast, Sanne Weijzen, Rakhee Banerjee, Peter C. Scacheri, Feng Tie, Manuel O. Dı́az, Peter J. Harte, Carl A. Stratton and Clodia Osipo and has published in prestigious journals such as Nature Medicine, Development and Cancer Research.

In The Last Decade

Andrei Zlobin

17 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrei Zlobin United States	13	1.1k	381	261	114	101	18	1.4k
Vikram Devgan United States	8	657 0.6×	306 0.8×	123 0.5×	70 0.6×	97 1.0×	10	888
Dario Antonini Italy	20	840 0.8×	400 1.0×	196 0.8×	60 0.5×	180 1.8×	40	1.2k
Sridevi Gottipati United States	7	900 0.8×	307 0.8×	289 1.1×	534 4.7×	61 0.6×	7	1.5k
Verónica Rodilla Spain	12	951 0.9×	557 1.5×	270 1.0×	155 1.4×	200 2.0×	14	1.4k
Alexandra Bell United Kingdom	10	704 0.6×	689 1.8×	218 0.8×	100 0.9×	168 1.7×	13	1.3k
Timothy K. MacLachlan United States	22	1.2k 1.1×	552 1.4×	187 0.7×	145 1.3×	356 3.5×	46	1.6k
Thomas Trimarchi United States	17	1.4k 1.3×	392 1.0×	528 2.0×	314 2.8×	78 0.8×	20	2.0k
Stephanie Stahl United States	11	756 0.7×	314 0.8×	110 0.4×	67 0.6×	115 1.1×	11	1.1k
Mary Barbara United States	15	768 0.7×	301 0.8×	162 0.6×	235 2.1×	86 0.9×	22	1.3k
Robert S. Mann United States	9	1.0k 0.9×	145 0.4×	109 0.4×	182 1.6×	119 1.2×	9	1.3k

Countries citing papers authored by Andrei Zlobin

Since Specialization

Citations

This map shows the geographic impact of Andrei Zlobin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrei Zlobin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrei Zlobin more than expected).

Fields of papers citing papers by Andrei Zlobin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrei Zlobin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrei Zlobin. The network helps show where Andrei Zlobin may publish in the future.

Co-authorship network of co-authors of Andrei Zlobin

This figure shows the co-authorship network connecting the top 25 collaborators of Andrei Zlobin. A scholar is included among the top collaborators of Andrei Zlobin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrei Zlobin. Andrei Zlobin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Szczepankiewicz, Andrzej A., Hanna Nieznańska, Andrei Zlobin, et al.. (2024). Cellular Distribution and Ultrastructural Changes in HaCaT Cells, Induced by Podophyllotoxin and Its Novel Fluorescent Derivative, Supported by the Molecular Docking Studies. International Journal of Molecular Sciences. 25(11). 5948–5948. 2 indexed citations

Zlobin, Andrei, et al.. (2024). Modern photo- and electrochemical approaches to aryl radical generation. Organic Chemistry Frontiers. 11(18). 5232–5277. 21 indexed citations

Perez, Edith, et al.. (2020). Binge Alcohol Exposure in Adolescence Impairs Normal Heart Growth. Journal of the American Heart Association. 9(9). e015611–e015611. 9 indexed citations

Peiffer, Daniel S., Debra Wyatt, Andrei Zlobin, et al.. (2019). DAXX Suppresses Tumor-Initiating Cells in Estrogen Receptor–Positive Breast Cancer Following Endocrine Therapy. Cancer Research. 79(19). 4965–4977. 32 indexed citations

Zlobin, Andrei, et al.. (2018). Abstract 5845: Roles for MLL2/ KMT2D or MLL3/ KMT2C in HER+ breast cancer stem cells. Cancer Research. 78(13_Supplement). 5845–5845. 1 indexed citations

Zlobin, Andrei, Debra Wyatt, Jeffrey Bloodworth, et al.. (2016). Abstract LB-121: DAXX is a novel Notch-1 gene target and biomarker of GSI-sensitivity in ER+ breast cancer. Cancer Research. 76(14_Supplement). LB–121.

Pandya, Kinnari, Debra Wyatt, Brian M. Gallagher, et al.. (2015). PKCα Attenuates Jagged-1–Mediated Notch Signaling in ErbB-2–Positive Breast Cancer to Reverse Trastuzumab Resistance. Clinical Cancer Research. 22(1). 175–186. 31 indexed citations

Albain, Kathy S., Andrei Zlobin, Kyle R. Covington, et al.. (2015). Abstract S4-03: Identification of a notch-driven breast cancer stem cell gene signature for anti-notch therapy in an ER+ presurgical window model. Cancer Research. 75(9_Supplement). S4–3. 2 indexed citations

Baker, Andrew T., Andrei Zlobin, & Clodia Osipo. (2014). Notch-EGFR/HER2 Bidirectional Crosstalk in Breast Cancer. Frontiers in Oncology. 4. 360–360. 72 indexed citations

10.

Weber, C., Anai N. Kothari, Philip Y. Wai, et al.. (2014). Osteopontin mediates an MZF1–TGF-β1-dependent transformation of mesenchymal stem cells into cancer-associated fibroblasts in breast cancer. Oncogene. 34(37). 4821–4833. 181 indexed citations

11.

Albain, KS, Andrei Zlobin, Prithi Rajan, et al.. (2011). S1-5: Modulation of Cancer and Stem Cell Biomarkers by the Notch Inhibitor MK-0752 Added to Endocrine Therapy for Early Stage ER+ Breast Cancer.. Cancer Research. 71(24_Supplement). S1–5. 17 indexed citations

12.

Tie, Feng, Rakhee Banerjee, Carl A. Stratton, et al.. (2009). CBP-mediated acetylation of histone H3 lysine 27 antagonizesDrosophilaPolycomb silencing. Development. 136(18). 3131–3141. 412 indexed citations

13.

Song, Lynda L., Andrei Zlobin, Pushpankur Ghoshal, et al.. (2005). Alteration of SMRT Tumor Suppressor Function in Transformed Non-Hodgkin Lymphomas. Cancer Research. 65(11). 4554–4561. 15 indexed citations

14.

Miao, Haixi, Nadia Carlesso, L L Shelly, et al.. (2003). Notch‐1 regulates cell death independently of differentiation in murine erythroleukemia cells through multiple apoptosis and cell cycle pathways. Journal of Cellular Physiology. 199(3). 418–433. 49 indexed citations

15.

Weijzen, Sanne, et al.. (2003). HPV16 E6 and E7 oncoproteins regulate Notch‐1 expression and cooperate to induce transformation. Journal of Cellular Physiology. 194(3). 356–362. 92 indexed citations

16.

Weijzen, Sanne, Paola Rizzo, Radhika Vaishnav, et al.. (2002). Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nature Medicine. 8(9). 979–986. 433 indexed citations

17.

Zlobin, Andrei, et al.. (2000). Toward The Rational Design of Cell Fate Modifiers Notch Signaling as a Target for Novel Biopharmaceuticals. Current Pharmaceutical Biotechnology. 1(1). 83–106. 43 indexed citations

18.

Zlobin, Andrei, et al.. (2000). Notch signaling as a target in multimodality cancer therapy.. PubMed. 2(1). 55–65. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact